BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36224266)

  • 1. Global microRNA expression profile in laryngeal carcinoma unveils new prognostic biomarkers and novel insights into field cancerization.
    Popov TM; Stancheva G; Kyurkchiyan SG; Petkova V; Panova S; Kaneva RP; Popova DP
    Sci Rep; 2022 Oct; 12(1):17051. PubMed ID: 36224266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proangiogenic signature in advanced laryngeal carcinoma after microRNA expression profiling.
    Popov TM; Giragosyan S; Petkova V; Stancheva G; Marinov T; Belitova M; Rangachev J; Popova D; Kaneva RP
    Mol Biol Rep; 2020 Jul; 47(7):5651-5655. PubMed ID: 32533400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of miR-29c-3p is associated with a poor prognosis in patients with laryngeal squamous cell carcinoma.
    Fang R; Huang Y; Xie J; Zhang J; Ji X
    Diagn Pathol; 2019 Oct; 14(1):109. PubMed ID: 31615536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New miRNA expression abnormalities in laryngeal squamous cell carcinoma.
    Cybula M; Wieteska Ƚ; Józefowicz-Korczyńska M; Karbownik MS; Grzelczyk WL; Szemraj J
    Cancer Biomark; 2016; 16(4):559-68. PubMed ID: 27002759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
    Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
    Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of miR-296-5p as predictive marker for radiotherapy resistance in early-stage laryngeal carcinoma.
    Maia D; de Carvalho AC; Horst MA; Carvalho AL; Scapulatempo-Neto C; Vettore AL
    J Transl Med; 2015 Aug; 13():262. PubMed ID: 26264462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low expression of miR-20b-5p indicates favorable prognosis in laryngeal squamous cell carcinoma, especially in patients with non-infiltrated regional lymph nodes.
    Pantazis TL; Giotakis AI; Karamagkiolas S; Giotakis I; Konstantoulakis M; Liakea A; Misiakos EP
    Am J Otolaryngol; 2020; 41(5):102563. PubMed ID: 32521298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High microRNA-23a expression in laryngeal squamous cell carcinoma is associated with poor patient prognosis.
    Zhang XW; Liu N; Chen S; Wang Y; Zhang ZX; Sun YY; Qiu GB; Fu WN
    Diagn Pathol; 2015 Apr; 10():22. PubMed ID: 25879432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma.
    Matsui D; Zaidi AH; Martin SA; Omstead AN; Kosovec JE; Huleihel L; Saldin LT; DiCarlo C; Silverman JF; Hoppo T; Finley GG; Badylak SF; Kelly RJ; Jobe BA
    Oncotarget; 2016 Dec; 7(49):81281-81291. PubMed ID: 27793030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulated microRNAs in laryngeal cancer: a comprehensive meta-analysis using a robust rank aggregation approach.
    Cao Z; Guo Y; Ao Y; Zhou S
    Future Oncol; 2020 Nov; 16(33):2723-2734. PubMed ID: 32812475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritumor Mucosa in Advanced Laryngeal Carcinoma Exhibits an Aberrant Proangiogenic Signature Distinctive from the Expression Pattern in Adjacent Tumor Tissue.
    Kyurkchiyan SG; Stancheva G; Petkova V; Panova S; Dobriyanova V; Stancheva I; Marinov V; Zahariev Z; Kaneva RP; Popov TM
    Cells; 2024 Apr; 13(7):. PubMed ID: 38607072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.
    Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J
    Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated miRNA and mRNA expression analysis uncovers drug targets in laryngeal squamous cell carcinoma patients.
    Lapa RML; Barros-Filho MC; Marchi FA; Domingues MAC; de Carvalho GB; Drigo SA; Kowalski LP; Rogatto SR
    Oral Oncol; 2019 Jun; 93():76-84. PubMed ID: 31109699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
    Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
    Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel insights into laryngeal squamous cell carcinoma from association study of aberrantly expressed miRNAs, lncRNAs and clinical features in Bulgarian patients.
    Garo Kyurkchiyan S; Miroslavov Popov T; Stancheva G; Rangachev J; Ivanov Mitev V; Petrova Popova D; Petrova Kaneva R
    J BUON; 2020; 25(1):357-366. PubMed ID: 32277655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma.
    Romani C; Salviato E; Paderno A; Zanotti L; Ravaggi A; Deganello A; Berretti G; Gualtieri T; Marchini S; D'Incalci M; Mattavelli D; Piazza C; Bossi P; Romualdi C; Nicolai P; Bignotti E
    Theranostics; 2021; 11(6):2987-2999. PubMed ID: 33456584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA-423-3p promotes tumor progression via modulation of AdipoR2 in laryngeal carcinoma.
    Guan G; Zhang D; Zheng Y; Wen L; Yu D; Lu Y; Zhao Y
    Int J Clin Exp Pathol; 2014; 7(9):5683-91. PubMed ID: 25337209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study reveals the potential of miR-31-3p and miR-196a-5p as non-invasive biomarkers in advanced laryngeal cancer.
    Kyurkchiyan SG; Popov TM; Shakola F; Rangachev J; Mitev VI; Kaneva R
    Folia Med (Plovdiv); 2021 Jun; 63(3):355-364. PubMed ID: 34196150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA expression patterns in oral squamous cell carcinoma: hsa-mir-99b-3p and hsa-mir-100-5p as novel prognostic markers for oral cancer.
    Jakob M; Mattes LM; Küffer S; Unger K; Hess J; Bertlich M; Haubner F; Ihler F; Canis M; Weiss BG; Kitz J
    Head Neck; 2019 Oct; 41(10):3499-3515. PubMed ID: 31355988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
    Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
    Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.